Cargando…

A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III

INTRODUCTION: A deficiency of glycogen debrancher enzyme in patients with glycogen storage disease type III (GSD III) manifests with hepatic, cardiac, and muscle involvement in the most common subtype (type a), or with only hepatic involvement in patients with GSD IIIb. OBJECTIVE AND METHODS: To des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hijazi, Ghada, Paschall, Anna, Young, Sarah P., Smith, Brian, Case, Laura E., Boggs, Tracy, Amarasekara, Sathya, Austin, Stephanie L., Pendyal, Surekha, El-Gharbawy, Areeg, Deak, Kristen L., Muir, Andrew J., Kishnani, Priya S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600151/ https://www.ncbi.nlm.nih.gov/pubmed/34820282 http://dx.doi.org/10.1016/j.ymgmr.2021.100821

Ejemplares similares

Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?
por: El-Gharbawy, Areeg, et al.
Publicado: (2022)

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
por: Jackson, David G., et al.
Publicado: (2023)

Diurnal variability of glucose tetrasaccharide (Glc(4)) excretion in patients with glycogen storage disease type III
por: Young, Sarah P., et al.
Publicado: (2020)

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations
por: Rossi, Alessandro, et al.
Publicado: (2020)

Characterization of a canine model of glycogen storage disease type IIIa
por: Yi, Haiqing, et al.
Publicado: (2012)

Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV
por: Yi, Haiqing, et al.
Publicado: (2016)

"Bull’s eye” appearance of hepatocellular adenomas in patients with glycogen storage disease type I — atypical magnetic resonance imaging findings: Two case reports
por: Vernuccio, Federica, et al.
Publicado: (2021)

Quantitative whole‐body magnetic resonance imaging in children with Pompe disease: Clinical tools to evaluate severity of muscle disease
por: Fernandes, Samuela A., et al.
Publicado: (2020)

A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme
por: Lim, Jeong-A, et al.
Publicado: (2020)

French recommendations for the management of glycogen storage disease type III
por: Wicker, Camille, et al.
Publicado: (2023)

Assessment of Dysphonia in Children with Pompe Disease Using Auditory-Perceptual and Acoustic/Physiologic Methods
por: Crisp, Kelly D., et al.
Publicado: (2021)

Use of waxy maize heat modified starch in the treatment of children between 2 and 5 years with glycogen storage disease type I: A retrospective study
por: Hijazi, Ghada, et al.
Publicado: (2019)

Rare form of autosomal dominant familial Cornelia de Lange syndrome due to a novel duplication in SMC3
por: Infante, Elena, et al.
Publicado: (2017)

Glycogen storage disease type III: modified Atkins diet improves myopathy
por: Mayorandan, Sebene, et al.
Publicado: (2014)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome
por: Sentner, Christiaan P., et al.
Publicado: (2016)

PSUN249 Starvation Ketoacidosis as the Presenting Finding of Glycogen Storage Disorder Type III
por: Fiacco, Nicholas, et al.
Publicado: (2022)

Neurological Characteristics of Pediatric Glycogen Storage Disease
por: Muzetti, Julio Henrique, et al.
Publicado: (2021)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Biomarkers in Glycogen Storage Diseases: An Update
por: Molares-Vila, Alberto, et al.
Publicado: (2021)

Dysregulation of Multiple Facets of Glycogen Metabolism in a Murine Model of Pompe Disease
por: Taylor, Kristin M., et al.
Publicado: (2013)

ON THE DIFFERING APPEARANCE OF INTRANUCLEAR AND CYTOPLASMIC GLYCOGEN IN LIVER CELLS IN GLYCOGEN STORAGE DISEASE
por: Sheldon, H., et al.
Publicado: (1962)

Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report
por: Ismail, Heba
Publicado: (2009)

Uniparental isodisomy of chromosome 1 results in glycogen storage disease type III with profound growth retardation
por: Ponzi, Emanuela, et al.
Publicado: (2019)

Clinical and Functional Characterization of Novel AGL Variants in Two Families with Glycogen Storage Disease Type III
por: Yu, Tingting, et al.
Publicado: (2023)

Development of high sustained anti-drug antibody titers and corresponding clinical decline in a late-onset Pompe disease patient after 11+ years on enzyme replacement therapy
por: Kim, Katherine H., et al.
Publicado: (2023)

Glycogen storage disease presenting as Cushing syndrome
por: Stefater, Margaret A., et al.
Publicado: (2019)

Modified Atkins ketogenic diet improves heart and skeletal muscle function in glycogen storage disease type III
por: FRANCINI-PESENTI, FRANCESCO, et al.
Publicado: (2019)

The biallelic novel pathogenic variants in AGL gene in a chinese patient with glycogen storage disease type III
por: Wang, Jing, et al.
Publicado: (2022)

Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature
por: Massimino, Elena, et al.
Publicado: (2023)

Small-Fiber Neuropathy in Pompe Disease: First Reported Cases and Prospective Screening of a Clinic Cohort
por: Hobson-Webb, Lisa D., et al.
Publicado: (2015)

Liver transplantation in glycogen storage disease type I
por: Boers, Susanna JB, et al.
Publicado: (2014)

Pulmonary Hypertension in Glycogen Storage Disease Type II
por: Li, Hui-Ping, et al.
Publicado: (2018)

Hepatic glycogen storage diseases are associated to microbial dysbiosis
por: Colonetti, Karina, et al.
Publicado: (2019)

Liver Transplantation for Glycogen Storage Disease Type IV
por: Liu, Min, et al.
Publicado: (2021)

Wernicke’s Encephalopathy: A Precipitation of Glycogen Storage Disease
por: Idris, Samah, et al.
Publicado: (2022)

Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
por: Pursell, Natalie, et al.
Publicado: (2018)

A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene
por: Choi, So Yoon, et al.
Publicado: (2018)

Manipulating the Expression of Glycogen Phosphorylase in Synechococcus elongatus PCC 7942 to Mobilize Glycogen Storage for Sucrose Synthesis
por: Dan, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oeho9kmerven1pcsuh083pp183